Discontinuation report APO-ALENDRONATE
| Report ID | 60163 |
| Drug Identification Number | 02248728 |
| Brand name | APO-ALENDRONATE |
| Common or Proper name | ALENDRONATE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALENDRONIC ACID |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 BLS |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-05-31 |
| Actual discontinuation date | |
| Remaining supply date | 2020-05-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.